Corneal Toxicity in Patients Treated by Belantamab Mafodotin

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

May 2, 2023

Study Completion Date

May 2, 2023

Conditions
Myeloma Multiple
Interventions
OTHER

Collection of datas

The collected data are : sex, age, date of first immunotherapy cycle, dose, date of first consultation, objective refraction in spheric equivalent, keratometry, visual acuity, microcyst-like epithelial changes (MECs), location and density, corneal toxicity grade and complementary exams (topography, in vivo confocal microscopy).

Trial Locations (10)

Unknown

CHU Dijon, Dijon

CHU de Limoges - Hôpital Dupuytren, Limoges

HCL- Croix Rousse, Lyon

Clinique Monticelli-Vélodrome, Marseille

CHRU de Nancy, Nancy

CHU Nice, Nice

APHP - Kremlin-Bicêtre, Paris

CHU Saint-Etienne, Saint-Etienne

CHRU Strasbourg, Strasbourg

CHU Toulouse, Toulouse

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER